India's Trade Deals Threaten Policy Control, Domestic Firms

ECONOMY
Whalesbook Logo
AuthorVihaan Mehta|Published at:
India's Trade Deals Threaten Policy Control, Domestic Firms
Overview

India's aggressive pursuit of Free Trade Agreements (FTAs) with nations like the UK and EU risks undermining its policy autonomy. Key provisions in government procurement and intellectual property rights could limit opportunities for domestic firms and generic drug producers, potentially hindering 'Make in India' and access to affordable medicines. Concerns are mounting that these deals may dilute industrial policy tools and impact local manufacturing.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Procurement Challenges Emerge

The India-UK Comprehensive Economic Partnership Agreement (CEPA) includes a 'no less favourable treatment' clause for goods, services, and suppliers. This allows UK firms to potentially compete on equal footing with Indian suppliers for government tenders, including those with a 20% domestic content requirement. This provision has drawn criticism, with concerns that it could crowd out Micro, Small, and Medium Enterprises (MSMEs) that rely on preferential access to government contracts. Experts warn that this clause dilutes one of India's few remaining industrial policy tools aimed at promoting domestic manufacturing, innovation, and jobs. While the agreement sets a threshold for UK companies to bid on tenders exceeding approximately ₹1.6 crore, and requires them to establish manufacturing units in India to remain competitive for larger contracts, the designation of UK firms with just 20% UK content as 'Class 2 Local Suppliers' grants them eligibility previously reserved for Indian firms, sparking debates about the reciprocal benefits for Indian businesses in the UK market.

Intellectual Property Rights and Pharmaceutical Access

FTAs, particularly with the EU, are also raising concerns regarding intellectual property (IP) rights. While these agreements aim to promote innovation and creativity, there are apprehensions that 'TRIPS-plus' provisions could restrict India's ability to produce and export affordable generic medicines, potentially impacting its role as the 'pharmacy of the developing world.' The EU-India FTA, while reaffirming the Doha Declaration on TRIPS and Public Health, aims for 'appropriate and effective protection and enforcement' of IP rights. However, critics argue that enhanced IP protections may still compromise public health objectives and access to medicines, as seen in past negotiations where the EU pushed for provisions beyond TRIPS standards.

Impact on 'Make in India' and Self-Reliance

The 'Make in India' and 'Atmanirbhar Bharat' (self-reliant India) initiatives, designed to bolster domestic manufacturing and economic independence, face potential headwinds from these trade agreements. The provisions allowing foreign firms greater access to government procurement, and potentially stricter IP regulations, could limit opportunities for domestic players, especially MSMEs. While FTAs are intended to boost exports and attract foreign investment, the current approach may be perceived as potentially restricting policy space for domestic industry and agriculture, particularly concerning new issues like digital trade. The challenge lies in balancing the benefits of market access and integration into global value chains with the imperative to protect and foster domestic capabilities.

Strategic Autonomy in Trade Negotiations

India's pursuit of FTAs, including those with the UK and EU, is framed within its doctrine of 'strategic autonomy.' However, the increasing interdependence of trade with geopolitical considerations means that 'autonomy' is becoming more conditional and negotiated. While these agreements aim to diversify trade partnerships and avoid over-reliance on any single axis, concerns remain about the potential for these pacts to restrict India's policy flexibility in areas critical for its socio-economic development. The government's strategy appears to be shifting towards a more pragmatic approach, seeking balanced FTAs that protect sensitive domestic sectors while encouraging competitiveness in others.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.